Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 4
1970 4
1971 1
1972 7
1973 2
1974 2
1975 6
1976 11
1977 5
1978 9
1979 8
1980 6
1981 6
1982 2
1983 6
1984 16
1985 16
1986 12
1987 17
1988 7
1989 10
1990 12
1991 25
1992 16
1993 24
1994 20
1995 9
1996 18
1997 29
1998 31
1999 27
2000 26
2001 28
2002 25
2003 21
2004 31
2005 29
2006 27
2007 12
2008 19
2009 11
2010 7
2011 11
2012 3
2013 4
2015 1
2016 5
2017 3
2018 3
2019 3
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

627 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
Breedveld FC, Kalden JR, Smolen JS. Breedveld FC, et al. Among authors: kalden jr. Semin Arthritis Rheum. 2019 Dec;49(3S):S1-S2. doi: 10.1016/j.semarthrit.2019.10.004. Epub 2019 Oct 31. Semin Arthritis Rheum. 2019. PMID: 31706626 No abstract available.
Emerging Therapies for Rheumatoid Arthritis.
Kalden JR. Kalden JR. Rheumatol Ther. 2016 Jun;3(1):31-42. doi: 10.1007/s40744-016-0032-4. Epub 2016 Jun 3. Rheumatol Ther. 2016. PMID: 27747522 Free PMC article. Review.
Advances in targeted therapy.
Breedveld FC, Kalden JR, Smolen JS. Breedveld FC, et al. Among authors: kalden jr. Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii1-ii2. doi: 10.1093/rheumatology/kew354. Rheumatology (Oxford). 2016. PMID: 27856653 No abstract available.
Advances in targeted therapies 2017.
Breedveld FC, Kalden JR, Smolen JS. Breedveld FC, et al. Among authors: kalden jr. Clin Immunol. 2018 Jan;186:1-2. doi: 10.1016/j.clim.2018.01.007. Epub 2018 Jan 31. Clin Immunol. 2018. PMID: 29378299 No abstract available.
Retrovirus-associated rheumatic syndromes.
Herrmann M, Neidhart M, Gay S, Hagenhofer M, Kalden JR. Herrmann M, et al. Among authors: kalden jr. Curr Opin Rheumatol. 1998 Jul;10(4):347-54. doi: 10.1097/00002281-199807000-00012. Curr Opin Rheumatol. 1998. PMID: 9725097 Review.
Etanercept: an introduction.
Grunke M, Kalden JR. Grunke M, et al. Among authors: kalden jr. Expert Rev Clin Immunol. 2005 Sep;1(3):313-23. doi: 10.1586/1744666X.1.3.313. Expert Rev Clin Immunol. 2005. PMID: 20476983
Advances in rheumatology: new targeted therapeutics.
Tak PP, Kalden JR. Tak PP, et al. Among authors: kalden jr. Arthritis Res Ther. 2011 May 25;13 Suppl 1(Suppl 1):S5. doi: 10.1186/1478-6354-13-S1-S5. Arthritis Res Ther. 2011. PMID: 21624184 Free PMC article. Review.
Controversies in COX-2 selective inhibition.
Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH. Simon LS, et al. Among authors: kalden jr. J Rheumatol. 2002 Jul;29(7):1501-10. J Rheumatol. 2002. PMID: 12136912 Review. No abstract available.
Lefunomide in combination therapy.
Kalden JR, Smolen JS, Emery P, van Riel PL, Dougados M, Strand CV, Breedveld FC. Kalden JR, et al. J Rheumatol Suppl. 2004 Jun;71:25-30. J Rheumatol Suppl. 2004. PMID: 15170905 Review.
Perspectives for TNF-alpha-targeting therapies.
Lorenz HM, Kalden JR. Lorenz HM, et al. Among authors: kalden jr. Arthritis Res. 2002;4 Suppl 3(Suppl 3):S17-24. doi: 10.1186/ar564. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110119 Free PMC article. Review.
627 results